Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psychopharmacology vs CBCT in Perinatal Distress
NCT06001021Completed
- Start
- Aug 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of escitalopram, sertraline and alprazolam in Perinatal depression (PPD) and anxiety disorder (4 arms). Primary endpoints: Parental Perinatal Distress Scale Score at 10 weeks, Multidimensional Scale for Perceived Social Support Score at 10 weeks and 3 more. Started Aug 2023; status: completed.
02
Drugs
escitalopramsertralinealprazolam
03
Conditions
Perinatal depression (PPD)anxiety disorder
Beyond the preview
Go deeper on NCT06001021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06001021.